BOSTON, Aug. 24, 2015 /PRNewswire/ — Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company’s […]

India and the European Union are taking steps to end a trade row sparked by an EU ban on Indian pharmaceutical products that New Delhi responded to by cancelling talks […]

Redwood City, Calif.-based Relypsa Inc. (RLYP) announced yesterday that it had signed a two-year detailing deal with Sanofi for the commercialization of a kidney disease drug. It also announced today […]

U.S. drugmaker Pfizer (PFE.N) gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira (HSP.N) after pledging to sell some drugs to allay […]

LAVAL, QUEBEC–(Marketwired – Aug. 4, 2015) – ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), (“ProMetic” or the “Corporation”) announced today that an orphan drug designation status has been granted for its human […]

OSAKA, Japan, July 30, 2015 /PRNewswire/ — Takeda Pharmaceutical Company Limited (“Takeda”) today announced the completion of the study to fulfill the post-marketing commitment and submissions of data to regulatory authorities […]

Sunesis Pharmaceuticals Inc said the U.S. Food and Drug Administration called for more clinical evidence before considering approval for its cancer drug, sending the company’s shares down 60 percent in […]

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for […]

Sanofi and Regeneron’s new cholesterol drug Praluent could be recommended for approval in Europe as early as this week, along with the world’s first malaria vaccine from GlaxoSmithKline. A European […]

Amgen Inc’s cholesterol fighting drug was approved by the European Commission, giving the keenly anticipated treatment a head start over a rival drug being developed by Regeneron Pharmaceuticals Inc and […]